Alethea Capital Management’s Gilead Sciences GILD Stock Holding History

Alethea Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,069	Closed	-$455K	–	44
2023 Q3	$455K	Buy	+6,069	New	+$467K	0.56%	10
2022 Q3	–	Sell	-8,850	Closed	-$547K	–	66
2022 Q2	$547K	Buy	+8,850	New	+$548K	0.68%	12
2021 Q3	–	Sell	-11,538	Closed	-$795K	–	95
2021 Q2	$795K	Buy	+11,538	New	+$770K	0.5%	16
2021 Q1	–	Sell	-4,922	Closed	-$287K	–	90
2020 Q4	$287K	Sell	4,922 -14,948	-75%	-$902K	0.14%	63
2020 Q3	$1.26M	Buy	+19,870	New	+$1.38M	0.85%	13
2018 Q1	–	Sell	-13,464	Closed	-$965K	–	88
2017 Q4	$965K	Buy	+13,464	New	+$1.02M	1.54%	18

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alethea Capital Management's GILD Position: Q4 2023 in Review

Alethea Capital Management sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 6,069 shares — an estimated $455K sold.

Alethea Capital Management first reported a position in GILD in Q4 2017 and held it in 6 quarters. The position peaked at $1.26M in Q3 2020. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

Alethea Capital Management reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
Alethea Capital Management sold 6,069 Gilead Sciences shares in Q4 2023, an estimated $455K.
Alethea Capital Management first reported a position in Gilead Sciences in Q4 2017 and held it in 6 quarters.
Alethea Capital Management's Gilead Sciences position peaked at $1.26M in Q3 2020.
1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Alethea Capital Management's 13F filing for Q4 2023, filed 15 Feb 2024.